Logo Logo Logo Logo Logo
  • Qui sommes-nous ?
    • Dirigeants
    • Notre équipe
    • Carrières
    • Développement commercial
  • Domaines de diagnostic
    • COVID-19
    • Innovation intelligente
  • Produits
    • Solutions de flux de travail
  • Actualités
  • Investisseurs
    • Calendrier institutionnel
    • Rapports financiers
    • Dirigeants
    • Assemblées générales
    • Autres informations réglementées
    • Contacts
    • AIM Rule 26 information
    • Gouvernement d’entreprise
  • Contact
  • Français
    • Anglais
  • Qui sommes-nous ?
    • Dirigeants
    • Notre équipe
    • Carrières
    • Développement commercial
  • Domaines de diagnostic
    • COVID-19
    • Innovation intelligente
  • Produits
    • Solutions de flux de travail
  • Actualités
  • Investisseurs
    • Calendrier institutionnel
    • Rapports financiers
    • Dirigeants
    • Assemblées générales
    • Autres informations réglementées
    • Contacts
    • AIM Rule 26 information
    • Gouvernement d’entreprise
  • Contact
  • Français
    • Anglais
Search:

13 Avr Innovative automation supports laboratory testing workflow

Posted at 17:34h in Blog, CO-Prep, COVID-19

Novacyt has unveiled the new CO-Prep™ Automated Liquid Handling System designed for use with the PROmate® COVID-19 assay workflows, which can also be used to support busy laboratories and private...

Read More

30 Nov Unpredictable challenges for respiratory virus treatment

Posted at 11:09h in Blog

Winter 2021/2022 could become the most challenging in decades for respiratory healthcare. There are many unknowns, such as the potential impact of circulating influenza or the trajectory of new COVID-19 variants...

Read More

10 Août Boosting reassurance for international travel through reliable COVID-19 testing

Posted at 12:44h in Blog, COVID-19, genesig qPCR Detection Kits

As international travel begins to re-open following the challenges of the COVID-19 pandemic, there’s a growing need for reliable, high-quality tests to satisfy the border requirements of different countries. The travel...

Read More

14 Juil Overwhelmed by COVID-19, are other serious infectious diseases neglected?

Posted at 09:56h in Blog, News, Videos, Webinar

The costs and healthcare challenges of tackling COVID-19 have threatened the world’s ability to address a steady rise in other serious infectious diseases. That’s the conclusion of a panel of experts...

Read More

24 Juin Don’t let COVID-19 distract you from a rise in other infectious diseases – stay alert!

Posted at 13:24h in Blog, COVID-19, News

The growth of the COVID-19 pandemic globally over the past 18 months has been exponential, and despite mitigating measures and the vaccine roll-out, the virus continues to mutate and spread. As...

Read More

12 Mai Continual testing is critical to avoid a virus ‘pole-vault’

Posted at 15:08h in Blog, COVID-19, Events

A multi-layered approach comprising vaccines, testing, lockdowns where necessary and medication will be essential for the foreseeable future in combatting COVID-19 – described as an “extraordinarily transmissible virus,” during the...

Read More

23 Avr Global bioinformatics surveillance drives innovation in SARS-CoV-2 variant detection tests

Posted at 15:19h in Behind the scenes, Blog, COVID-19, genesig qPCR Detection Kits

Market-leading intelligence is the catalyst behind Novacyt’s ability to anticipate - and respond - to emerging new SARS-CoV-2 variants. Global tracking of virus mutations enables its R & D division to...

Read More

14 Avr Novacyt Group: PathFlow® technology and knowledge underpin our drive for continued innovation

Posted at 12:11h in Blog, COVID-19

Advancing technology and a unique wealth of knowledge are the driving forces behind innovative development in our PathFlow® portfolio of diagnostic tests for infectious diseases. Our latest addition to the range...

Read More

01 Avr PathFlow®: Future innovation of COVID-19 Lateral Flow Testing

Posted at 14:07h in Blog, COVID-19, News

PathFlow®: Future innovation of COVID-19 Lateral Flow Testing Advancing technology and a unique wealth of knowledge are the driving forces behind innovative development in our PathFlow® portfolio of diagnostic tests...

Read More

04 Mar Evolution of testing and sequencing during COVID-19 is vital to future pandemic control

Posted at 14:24h in Blog, COVID-19, Events

The advances in testing and genome sequencing during the COVID-19 pandemic will be crucial to predicting and managing future pandemics, according to scientific discussion during the NovaTalk webinar on February...

Read More
  • 1
  • 2
  • 3
  • 4

Qui sommes-nous?


Novacyt est une société mondiale leader dans le domaine du diagnostic. Nous protégeons les personnes et la société dans la lutte contre les maladies infectieuses.

Société


York House, School Lane, Chandlers Ford, Eastleigh, SO53 4DG

Novacyt UK Holdings - 12031776
Novacyt SA - 491062527

Rapports financiers


Présentation Investisseurs Septembre 2022

© 2022 Novacyt | Politique de confidentialité | Propriété intellectuelle | Conditions d’utilisation

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Enregistrer & appliquer